George S. Karagiannis, D.V.M, Ph.D. is an assistant professor in the Department of Microbiology and Immunology at the Albert Einstein College of Medicine, Bronx, NY, USA, and also affiliated with the Gruss-Lipper Biophotonics Center, the Integrated Imaging Program for Cancer Research (IIPCR), the Montefiore-Einstein Cancer Center (MECC) and its Tumor Microenvironment and Metastasis Program, and the Cancer Dormancy and Tumor Microenvironment Institute (CDTMI). He holds a Ph.D. in Cancer Biology from the University of Toronto, Canada, and a Degree in Veterinary Medicine (D.V.M.) from Aristotle University of Thessaloniki, Greece. His scientific contributions (>50 peer-reviewed, primary research articles and review articles) have appeared in highly esteemed journals and specialized society journals in the fields of cancer biology, molecular oncology, cancer proteomics, and translational medicine. His most prominent publications have appeared in Science Translational Medicine, Molecular and Cellular Proteomics, Nature Communications, Nature Cancer, Seminars in Cancer Biology, The Journal of Biological Chemistry, Molecular Cancer Therapeutics, Molecular Cancer Research, and Molecular Oncology. He is a recipient of the meritorious NCI Pathway to Independence Award (K99/R00). His current research efforts embody the effects of neoadjuvant chemotherapy on the primary tumor microenvironment, as well as chemotherapy-driven immunotoxicity on primary and secondary lymphoid organs with an emphasis on signaling perturbations involving chemokine/cytokine signaling.